Combined active-passive immunization against tetanus in man. 1967

L J Mahoney, and M A Aprile, and P J Moloney

A schedule for the prevention of tetanus in the injured, which has been in operation in the emergency department of a large hospital for over two years, is proposed. For the majority of nonimmunized persons, it is recommended that a dose of toxoid and 50 units tetanus immune globulin (human) (TIGH) be given, in separate sites, to be followed later by additional doses of toxoid for the completion of active immunization. Combined active-passive immunization with tetanus toxoid and 50 units TIGH gives a low level of passive immunity and stimulates early onset of active immunization. In combined active-passive immunization, adsorbed tetanus toxoid produced a significantly higher response than the fluid toxoid. The injection of 400 units TIGH somewhat suppressed the induction of immunity following the first dose of AlPO(4)-tetanus toxoid.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus
D013745 Tetanus Toxoid Tetanus Vaccine,Toxoid, Tetanus,Vaccine, Tetanus

Related Publications

L J Mahoney, and M A Aprile, and P J Moloney
April 1976, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
L J Mahoney, and M A Aprile, and P J Moloney
July 1965, The Medical journal of Australia,
L J Mahoney, and M A Aprile, and P J Moloney
September 1964, Orvosi hetilap,
L J Mahoney, and M A Aprile, and P J Moloney
January 1952, Zentralblatt fur Chirurgie,
L J Mahoney, and M A Aprile, and P J Moloney
January 1986, Medicinski pregled,
L J Mahoney, and M A Aprile, and P J Moloney
April 1966, Connecticut medicine,
L J Mahoney, and M A Aprile, and P J Moloney
January 1918, Medical bulletin (Paris, France),
L J Mahoney, and M A Aprile, and P J Moloney
September 1978, Immunology,
L J Mahoney, and M A Aprile, and P J Moloney
November 1964, The New England journal of medicine,
L J Mahoney, and M A Aprile, and P J Moloney
March 1948, The Journal of hygiene,
Copied contents to your clipboard!